基于全血细胞计和PBMV在风湿性额头骨狭窄症中的成功,新的炎症标志物
Nima Ghavamikia1, Mohammad Sahebjam2, Tahereh Davarpasand2
1Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Biomarkers in medicine
|July 28, 2025
概括
系统性炎症反应指数 (SIRI) 有效地预测了皮肤透气球中膜整形术 (PBMV) 在风湿性中膜狭窄症 (RMS) 患者的成功. 较高的SIRI水平与增加的并发症和较差的结果相关.
科学领域:
- 心脏病学 心脏病学
- 炎症研究 炎症研究
- 医学诊断 医学诊断 医学诊断
背景情况:
- 炎症标志物与疾病严重程度和风湿性关节狭窄症 (RMS) 的结果有关.
- 较新的炎症指数,全身免疫炎症指数 (SII) 和全身炎症反应指数 (SIRI),需要在经过皮肤气球 mitra valvuloplasty (PBMV) 的 RMS 患者中进一步调查.
研究的目的:
- 探索SII和SIRI之间的关联以及接受PBMV的RMS患者的临床结果.
- 评估SII和SIRI对PBMV成功和并发症的预测价值.
主要方法:
- 评估了131名接受PBMV治疗的严重RMS患者的队列.
- 分析了手术前的炎症标志物,心声学数据,威尔金斯得分和三年后的并发症.
- ROC曲线和多变量逻辑回归确定了预测关联.
主要成果:
- 较低的系统性肺压和较年轻的年龄预测了更大的PBMV成功.
- 副心脏反 (47.5%) 和再入院 (27.5%) 是常见的并发症.
- 较高的NLR,MLR,SII和SIRI与较高的威尔金斯分数相关;SIRI独立预测了PBMV的成功.
结论:
- 斯里显示了强大的预测能力,PBMV成功 (71%的灵敏度,80%的特异性).
- 在严重的RMS患者中,SIRI与并发症和中期结果有关.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
59
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
59
01:26Mitral Stenosis III: Medical Management
23
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
23
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37
01:21Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
53
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
53
01:25Mitral Regurgitation III: Medical Management
31
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
31